The Economic Times

Once-a-week insulin launched in India, but doctors say it won't replace daily shots for all

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest Awiqli is an additional option, not a complete replacement for daily insulin. It is best suited for patients who still produce some insulin naturally. This innovation aims to improve treatment adherence and manage blood sugar levels effectively.